|
DE2837168A1
(de)
|
1978-08-25 |
1980-03-06 |
Blutspendedienst Dt Rote Kreuz |
Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
|
|
US4362661A
(en)
|
1979-08-09 |
1982-12-07 |
Teijin Limited |
Immunoglobulin composition having a high monomer content, and process for production thereof
|
|
CA1153695A
(en)
|
1979-08-30 |
1983-09-13 |
Syoji Ono |
S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
|
|
US4374763A
(en)
|
1979-09-17 |
1983-02-22 |
Morishita Pharmaceutical Co., Ltd. |
Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
|
|
US4396608A
(en)
|
1981-08-24 |
1983-08-02 |
Cutter Laboratories |
Intravenously injectable immune serum globulin
|
|
US5702699A
(en)
|
1982-09-23 |
1997-12-30 |
Cetus Corporation |
Process for the recovery of lipophilic proteins
|
|
US4681713A
(en)
|
1984-03-15 |
1987-07-21 |
Toyo Boseki Kabushiki Kaisha |
Method of making a hollow fiber membrane for dialysis
|
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
|
US6673347B1
(en)
|
1986-04-30 |
2004-01-06 |
Gryphon Therapeutics |
Polypeptide and protein derivatives and process for their preparation
|
|
GB8628104D0
(en)
|
1986-11-25 |
1986-12-31 |
Connaught Lab |
Pasteurization of immunoglobin solutions
|
|
DE3640513A1
(de)
|
1986-11-27 |
1988-06-09 |
Biotest Pharma Gmbh |
Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
|
|
JP2547556B2
(ja)
|
1987-02-06 |
1996-10-23 |
株式会社 ミドリ十字 |
ｒ−グロブリンの液状製剤
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
US5395760A
(en)
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
|
ATE194384T1
(de)
|
1989-09-12 |
2000-07-15 |
Hoffmann La Roche |
Tnf-bindende proteine
|
|
DE3939346A1
(de)
|
1989-11-29 |
1991-06-06 |
Behringwerke Ag |
Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
|
|
US5945098A
(en)
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
|
US5177194A
(en)
|
1990-02-01 |
1993-01-05 |
Baxter International, Inc. |
Process for purifying immune serum globulins
|
|
GB9017002D0
(en)
|
1990-08-02 |
1990-09-19 |
Health Lab Service Board |
Improved method for the purification of erwina l-asparaginase
|
|
JP3179538B2
(ja)
|
1990-12-11 |
2001-06-25 |
ノバルティス アクチエンゲゼルシャフト |
安定なヒトカルシトニンの水性溶液
|
|
US5110910A
(en)
|
1991-03-25 |
1992-05-05 |
Miles Inc. |
Virucidal euglobulin precipitation
|
|
US5256571A
(en)
|
1991-05-01 |
1993-10-26 |
Cytyc Corporation |
Cell preservative solution
|
|
JP2723671B2
(ja)
|
1991-12-20 |
1998-03-09 |
山之内製薬株式会社 |
ＧＰ▲ＩＩ▼ｂ／▲ＩＩＩ▼ａと反応性のヒト型化抗体
|
|
US6004555A
(en)
|
1992-03-05 |
1999-12-21 |
Board Of Regents, The University Of Texas System |
Methods for the specific coagulation of vasculature
|
|
US5298410A
(en)
|
1993-02-25 |
1994-03-29 |
Sterling Winthrop Inc. |
Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
|
|
US5484892A
(en)
|
1993-05-21 |
1996-01-16 |
Dana-Farber Cancer Institute, Inc. |
Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
|
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
|
GB9401448D0
(en)
|
1994-01-26 |
1994-03-23 |
Ciba Geigy Ag |
Stable dry powders
|
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
|
ES2251723T3
(es)
|
1994-08-12 |
2006-05-01 |
Immunomedics, Inc. |
Inmunoconjugados y anticuerpos humanizados especificos para linfoma de celulas b y celulas de leucemia.
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
DK0929578T3
(da)
|
1996-02-09 |
2003-08-25 |
Abbott Lab Bermuda Ltd |
Humane antistoffer, der binder human TNFalfa
|
|
TW518219B
(en)
|
1996-04-26 |
2003-01-21 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
|
JP2000515857A
(ja)
|
1996-07-18 |
2000-11-28 |
シーエスエル リミテッド |
免疫グロブリン溶液の低温殺菌
|
|
TW491855B
(en)
|
1996-08-07 |
2002-06-21 |
Csl Ltd |
Purification of immunoglobulins
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
|
US5886154A
(en)
|
1997-06-20 |
1999-03-23 |
Lebing; Wytold R. |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
|
JP3679406B2
(ja)
|
1998-05-20 |
2005-08-03 |
協和醗酵工業株式会社 |
遺伝子組換え抗体
|
|
US6436897B2
(en)
|
1998-06-01 |
2002-08-20 |
Celtrix Pharmaceuticals, Inc. |
Pharmaceutical formulations for IGF/IGFBP
|
|
DK2270044T3
(en)
|
1998-06-09 |
2015-01-26 |
Csl Behring Ag |
Liquid immunoglobulin G (IgG) product
|
|
US6610206B1
(en)
|
1998-10-20 |
2003-08-26 |
Advanced Renal Technologies |
Buffered compositions for dialysis
|
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
|
US7294481B1
(en)
|
1999-01-05 |
2007-11-13 |
Immunex Corporation |
Method for producing recombinant proteins
|
|
DK1149114T3
(da)
|
1999-02-03 |
2014-06-23 |
Amgen Inc |
Polypeptider, der er involveret ved et immunrespons
|
|
JP4360758B2
(ja)
|
1999-04-08 |
2009-11-11 |
ジェネンテック・インコーポレーテッド |
逆の電荷のポリペプチド類をベースにした組成物
|
|
PT1181036E
(pt)
|
1999-04-09 |
2008-10-03 |
Ortho Mcneil Pharm Inc |
Composições farmacêuticas de eritropoietina
|
|
US20040220103A1
(en)
|
1999-04-19 |
2004-11-04 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
|
US20010021380A1
(en)
|
1999-04-19 |
2001-09-13 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
|
AU4363200A
(en)
|
1999-04-19 |
2000-11-02 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical desorders
|
|
DE60031999T2
(de)
|
1999-10-04 |
2007-06-06 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Stabilisierte flüssige polypeptid-haltige pharmazeutische zusammensetzungen
|
|
DE60039783D1
(de)
|
1999-12-14 |
2008-09-18 |
Genentech Inc |
Lfa-1 antagonisten und tnf-alpha antagonisten zur
|
|
AU2262501A
(en)
|
1999-12-16 |
2001-06-25 |
Amgen, Inc. |
Tnfr/opg-like molecules and uses thereof
|
|
WO2001058473A1
(en)
|
2000-02-10 |
2001-08-16 |
Wyeth |
Method of treating or inhibiting cellular injury or cell death
|
|
CA2396793A1
(en)
|
2000-02-16 |
2001-08-23 |
Genentech, Inc. |
Uses of agonists and antagonists to modulate activity of tnf-related molecules
|
|
WO2002008417A1
(fr)
|
2000-07-25 |
2002-01-31 |
Takeda Chemical Industries, Ltd. |
Procede de production d'une proteine de recombinaison
|
|
WO2002011753A1
(en)
|
2000-08-04 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
AU2002213441B2
(en)
|
2000-10-12 |
2006-10-26 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
NZ526569A
(en)
|
2000-12-14 |
2005-07-29 |
Fujisawa Pharmaceutical Co |
Silenced anti-CD28 antibodies and use thereof for inducing T-cell tolerance, providing immunosupression and treating organ or tissue transplant rejection
|
|
US6693173B2
(en)
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
|
BRPI0116728B1
(pt)
|
2001-01-05 |
2018-10-30 |
Pfizer Inc. |
anticorpos para receptor de fator de crescimento i semelhante à insulina
|
|
ES2184594B1
(es)
|
2001-01-17 |
2004-01-01 |
Probitas Pharma Sa |
Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
|
|
JP2005505494A
(ja)
|
2001-02-23 |
2005-02-24 |
イミュネックス・コーポレーション |
活性タンパク質の回収増加
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
CN1650393A
(zh)
|
2001-06-25 |
2005-08-03 |
皇家菲利浦电子有限公司 |
高压气体放电灯及其制造方法
|
|
PH12012502440A1
(en)
|
2001-06-26 |
2013-06-17 |
Amgen Inc |
Antibodies to opgl
|
|
IL160358A0
(en)
*
|
2001-08-23 |
2004-07-25 |
Genmab As |
Human antibodies specific for interleukin 15 (il-15)
|
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
|
IL159422A0
(en)
|
2001-09-20 |
2004-06-01 |
Cornell Res Foundation Inc |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
|
|
JP5290489B2
(ja)
|
2001-11-08 |
2013-09-18 |
アッヴィ・バイオセラピューティクス・インコーポレイテッド |
Ｉｇｇ抗体の安定な液体医薬製剤
|
|
AU2002359495A1
(en)
|
2001-11-30 |
2003-06-17 |
Centocor, Inc. |
Anti-tnf antibodies, compositions, methods and uses
|
|
WO2003059935A2
(en)
|
2001-12-21 |
2003-07-24 |
Immunex Corporation |
Methods for purifying protein
|
|
AU2003211990A1
(en)
|
2002-02-14 |
2003-09-04 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing solution pharmaceuticals
|
|
US20040001828A1
(en)
|
2002-02-21 |
2004-01-01 |
Joseph Tuscano |
Treatment methods using anti-CD22 antibodies
|
|
PT1946776T
(pt)
|
2002-02-27 |
2017-03-17 |
Immunex Corp |
Composição de tnfr-fc estabilizada compreendendo arginina
|
|
US6872549B2
(en)
|
2002-03-27 |
2005-03-29 |
Immunex Corporation |
Methods for increasing polypeptide production
|
|
WO2003086289A2
(en)
|
2002-04-05 |
2003-10-23 |
Amgen Inc. |
Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
|
|
DE10218570B4
(de)
|
2002-04-26 |
2007-10-18 |
Lohmann Gmbh & Co Kg |
Acrylatcopolymere und daraus erhältliche Haftklebemassen zum Verkleben von niederenergetischen Oberflächen sowie ihre Verwendung
|
|
CA2478925C
(en)
|
2002-04-26 |
2016-06-07 |
Robert Lee Fahrner |
Non-affinity purification of proteins
|
|
US20030206898A1
(en)
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
GB0210121D0
(en)
|
2002-05-02 |
2002-06-12 |
Celltech R&D Ltd |
Biological products
|
|
WO2004001007A2
(en)
|
2002-06-21 |
2003-12-31 |
Idec Pharmaceuticals Corporation |
Buffered formulations for concentrating antibodies and methods of use thereof
|
|
US20040219142A1
(en)
|
2002-07-19 |
2004-11-04 |
Abbott Laboratories S.A. |
Treatment of skin and nail disorders using TNFalpha inhibitors
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
CA2504134C
(en)
|
2002-11-01 |
2012-03-06 |
Bayer Healthcare Llc |
Process for concentration of macromolecules
|
|
US20040086532A1
(en)
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
CN101287484B
(zh)
|
2002-12-20 |
2012-10-10 |
安姆根有限公司 |
抑制肌肉生长抑制素的结合剂
|
|
WO2004083248A1
(en)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
|
CN1798575A
(zh)
|
2003-04-04 |
2006-07-05 |
健泰科生物技术公司 |
高浓度抗体和蛋白制剂
|
|
US7456147B2
(en)
|
2003-05-14 |
2008-11-25 |
Dow Corning, Corporation |
Controlled release of active agents utilizing repeat sequence protein polymers
|
|
EP1631317A2
(en)
|
2003-06-06 |
2006-03-08 |
Regeneron Pharmaceuticals, Inc. |
Use of vegf inhibitors for tumor regression
|
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
|
MXPA06004853A
(es)
|
2003-11-07 |
2006-07-06 |
Immunex Corp |
Anticuerpos que se aglutinan al receptor 4 de interleucina.
|
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
|
RU2390353C2
(ru)
|
2004-02-12 |
2010-05-27 |
Мерк Патент Гмбх |
Высококонцентрированные жидкие композиции анти-egfr антител
|
|
US20070292346A1
(en)
|
2004-03-25 |
2007-12-20 |
Rong Fan |
Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
|
|
US8333995B2
(en)
|
2004-05-12 |
2012-12-18 |
Baxter International, Inc. |
Protein microspheres having injectable properties at high concentrations
|
|
JPWO2006003999A1
(ja)
|
2004-07-05 |
2008-07-31 |
財団法人化学及血清療法研究所 |
ヒト抗ヒトｂ７ｒｐ−１抗体およびその抗体フラグメント
|
|
JP5015774B2
(ja)
*
|
2004-07-29 |
2012-08-29 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ジフルオロ置換複素環化合物および液晶媒体における構成要素としてのその使用
|
|
TW200621282A
(en)
|
2004-08-13 |
2006-07-01 |
Wyeth Corp |
Stabilizing formulations
|
|
TWI364458B
(en)
|
2004-08-27 |
2012-05-21 |
Wyeth Res Ireland Ltd |
Production of tnfr-lg
|
|
US20080312425A1
(en)
|
2004-08-30 |
2008-12-18 |
Lonza Biologics Plc. |
Ion Exchange Chromatography and Purification of Antibodies
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
WO2006064373A2
(en)
|
2004-12-16 |
2006-06-22 |
Genzyme Polyclonals S.A.S. |
Methods of purifying immunologlobulins
|
|
JP4498939B2
(ja)
|
2005-02-01 |
2010-07-07 |
東京応化工業株式会社 |
ポジ型レジスト組成物およびレジストパターン形成方法
|
|
US8597709B2
(en)
|
2005-04-12 |
2013-12-03 |
Inovobiologic Inc. |
Dietary supplement and methods of use
|
|
MX2007015476A
(es)
|
2005-06-14 |
2008-02-25 |
Amgen Inc |
Formulaciones de proteina autoamortiguadoras.
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20070049732A1
(en)
|
2005-09-01 |
2007-03-01 |
Zurlo Eugene J |
Ultra-high yield intravenous immune globulin preparation
|
|
JP5161779B2
(ja)
|
2005-09-21 |
2013-03-13 |
バーコン ニュートラサイエンス （エムビー） コーポレイション |
等電沈殿を含むキャノーラタンパク質単離物の調製
|
|
US8067350B2
(en)
|
2005-12-15 |
2011-11-29 |
Kimberly-Clark Worldwide, Inc. |
Color changing cleansing composition
|
|
US20070202051A1
(en)
|
2006-02-10 |
2007-08-30 |
Pari Gmbh |
Aerosols for sinunasal drug delivery
|
|
MX2008013508A
(es)
|
2006-04-21 |
2008-10-31 |
Novartis Ag |
Composiciones farmaceuticas de anticuerpos antagonistas anti-cd40.
|
|
JP2009534390A
(ja)
|
2006-04-21 |
2009-09-24 |
アムジェン インコーポレイテッド |
生物医薬品製剤のための緩衝剤
|
|
WO2008033556A2
(en)
|
2006-09-15 |
2008-03-20 |
Barofold, Inc. |
High pressure treatment of proteins for reduced immunogenicity
|
|
WO2008057240A2
(en)
|
2006-10-27 |
2008-05-15 |
Abbott Biotechnology Ltd. |
Crystalline anti-htnfalpha antibodies
|
|
JP5577098B2
(ja)
|
2006-12-21 |
2014-08-20 |
アムジエン・インコーポレーテツド |
ポリペプチドを含有する安定な緩衝化された製剤
|
|
TWI543768B
(zh)
|
2007-11-30 |
2016-08-01 |
艾伯維生物技術有限責任公司 |
蛋白質調配物及製造其之方法
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
EP2249801A2
(en)
*
|
2008-02-07 |
2010-11-17 |
Amgen Inc. |
Stabilized protein compositions
|
|
EP2276527B1
(en)
|
2008-05-20 |
2018-02-28 |
Avant Medical Corp. |
Autoinjector system
|
|
US8177749B2
(en)
|
2008-05-20 |
2012-05-15 |
Avant Medical Corp. |
Cassette for a hidden injection needle
|
|
US8052645B2
(en)
|
2008-07-23 |
2011-11-08 |
Avant Medical Corp. |
System and method for an injection using a syringe needle
|
|
CN102159204B
(zh)
*
|
2008-09-19 |
2015-04-01 |
辉瑞公司 |
稳定的液体抗体制剂
|
|
EP2362767B1
(en)
*
|
2008-10-29 |
2017-12-06 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
AR076640A1
(es)
|
2009-03-06 |
2011-06-29 |
Genentech Inc |
Formulacion con anticuerpo. metodo para estabilizar anticuerpo. articulo de manufactura
|
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
|
SG190069A1
(en)
|
2010-11-11 |
2013-06-28 |
Abbvie Biotechnology Ltd |
IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS
|
|
US9084849B2
(en)
*
|
2011-01-26 |
2015-07-21 |
Kaleo, Inc. |
Medicament delivery devices for administration of a medicament within a prefilled syringe
|
|
BR112013026883A2
(pt)
*
|
2011-04-20 |
2021-12-07 |
Sandoz Ag |
Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica
|
|
EP2699293B8
(en)
|
2011-04-20 |
2022-07-20 |
Amgen Inc. |
Autoinjector apparatus
|
|
UY34105A
(es)
|
2011-06-03 |
2012-07-31 |
Lg Life Sciences Ltd |
Formulación líquida estable de etanercept
|
|
CN113244374A
(zh)
|
2011-07-01 |
2021-08-13 |
生物基因Ma公司 |
无精氨酸的tnfr:fc-融合多肽组合物及使用方法
|
|
HK1200718A1
(en)
|
2011-10-18 |
2015-08-14 |
科荣生生物科学公司 |
Etanercept formulations stabilized with sodium chloride
|
|
US20150150982A1
(en)
*
|
2012-06-12 |
2015-06-04 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical formulation for a therapeutic antibody
|
|
BR112015000078A2
(pt)
|
2012-07-05 |
2017-10-03 |
Unitract Syringe Pty Ltd |
Injetor automático
|
|
IN2015KN00005A
(https=)
*
|
2012-07-09 |
2015-07-31 |
Coherus Biosciences Inc |
|
|
EA031324B1
(ru)
*
|
2012-09-11 |
2018-12-28 |
Кохерус Байосайенсис, Инк. |
Правильно свернутый этанерцепт с высокой чистотой и высоким уровнем выхода
|
|
KR102132050B1
(ko)
*
|
2012-10-26 |
2020-07-10 |
루핀 아틀란티스 홀딩스 에스에이 |
티엔에프알에프씨 융합 단백질의 안정한 약학 조성물
|
|
EP2919812A4
(en)
*
|
2012-11-19 |
2016-05-18 |
Merck Sharp & Dohme |
Liquid formulations for TNFR: FC fusion proteins
|
|
JP6026002B2
(ja)
*
|
2012-11-27 |
2016-11-16 |
アルテオジェン インコーポレイテッド |
タンパク質とＦｃドメインを融合した融合タンパク質の安定化用組成物
|
|
AR094458A1
(es)
|
2012-12-06 |
2015-08-05 |
Iams Co |
Alimento con formas perceptibles para mascotas
|
|
US9452138B2
(en)
|
2012-12-28 |
2016-09-27 |
Abbott Cardiovascular Systems Inc. |
Delivery of biologic therapeutics
|
|
CA2904661C
(en)
|
2013-03-15 |
2022-03-15 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
BR112015027764A2
(pt)
*
|
2013-05-02 |
2017-08-29 |
Mabxience S A |
Formulações alternativas para os polipeptídeos de fusão de tnfr: fc
|
|
SI3060229T1
(sl)
|
2013-10-24 |
2021-11-30 |
Astrazeneca Ab |
Stabilne vodne formulacije protiteles
|
|
EP3073992A4
(en)
|
2013-11-29 |
2017-09-13 |
Ares Trading S.A. |
A liquid formulation of a fusion protein comprising tnfr and fc region
|
|
ES2733298T3
(es)
|
2014-07-18 |
2019-11-28 |
Sandoz Ag |
Cuantificación de TNFR2:Fc plegado erróneamente
|
|
EP3733228B1
(en)
|
2014-08-28 |
2024-03-06 |
UNL Holdings LLC |
Sensor systems for drug delivery devices
|
|
DK3185934T3
(en)
|
2014-08-28 |
2018-10-01 |
Unl Holdings Llc |
SKIN SENSORS FOR PHARMACEUTICAL ADMINISTRATION DEVICES
|
|
AU2015371381A1
(en)
|
2014-12-22 |
2017-07-20 |
Ares Trading S.A. |
Liquid pharmaceutical composition
|
|
KR20170138426A
(ko)
|
2015-03-13 |
2017-12-15 |
삼성바이오에피스 주식회사 |
항-tnf-알파 폴리펩티드 조성물 및 그 용도
|
|
US9763976B1
(en)
|
2016-08-02 |
2017-09-19 |
Zo Skin Health, Inc. |
Composition and method for treating skin conditions
|
|
AU2017345490B2
(en)
|
2016-10-21 |
2022-07-07 |
Amgen Inc. |
Pharmaceutical formulations and methods of making the same
|